{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:39:32Z","timestamp":1783593572464,"version":"3.55.0"},"reference-count":120,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.berh.2023.101864","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T11:53:02Z","timestamp":1692791582000},"page":"101864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Translational implications of newly characterized pathogenic pathways in systemic lupus erythematosus"],"prefix":"10.1016","volume":"37","author":[{"given":"Mariele","family":"Gatto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Depascale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Luisa","family":"Stefanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Schrezenmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"D\u00f6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2023.101864_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/ard-2022-223741","article-title":"Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets","author":"Crow","year":"2023","journal-title":"Ann Rheum Dis Published Online First: February"},{"key":"10.1016\/j.berh.2023.101864_bib2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.autrev.2012.09.003","article-title":"Emerging and critical issues in the pathogenesis of lupus","volume":"12","author":"Gatto","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2023.101864_bib3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ng.81","article-title":"Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci","volume":"40","author":"Harley","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.berh.2023.101864_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/gene.2014.23","article-title":"GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region","volume":"15","author":"Armstrong","year":"2014","journal-title":"Gene Immun"},{"key":"10.1016\/j.berh.2023.101864_bib5","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/art.39504","article-title":"Genome-wide association study in an Amerindian ancestry population reveals novel systemic lupus erythematosus risk loci and the role of European admixture","volume":"68","author":"Alarc\u00f3n-Riquelme","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib6","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12089","article-title":"Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity","volume":"5","author":"Raj","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.berh.2023.101864_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.889296","article-title":"Construction and application of polygenic risk scores in autoimmune diseases","volume":"13","author":"Khunsriraksakul","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib8","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41467-021-21049-y","article-title":"Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.berh.2023.101864_bib9","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/annrheumdis-2020-219209","article-title":"Meta-analysis of 208370 east asians identifies 113 susceptibility loci for systemic lupus erythematosus","volume":"80","author":"Yin","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101864_bib10","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.3389\/fimmu.2018.02496","article-title":"Monogenic lupus: a developing paradigm of disease","volume":"9","author":"Alperin","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib11","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1093\/hmg\/ddy280","article-title":"Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans","volume":"27","author":"Hanscombe","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.berh.2023.101864_bib12","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190668","article-title":"A\u00a0super enhancer controls expression and chromatin architecture within the MHC class II locus","volume":"217","author":"Majumder","year":"2020","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.berh.2023.101864_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143654","article-title":"A\u00a0longitudinal and transancestral analysis of DNA methylation patterns and disease activity in lupus patients","volume":"5","author":"Coit","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.berh.2023.101864_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jaut.2018.09.007","article-title":"Epigenome-wide association study of peripheral blood mononuclear cells in systemic lupus erythematosus: identifying DNA methylation signatures associated with interferon-related genes based on ethnicity and SLEDAI","volume":"96","author":"Joseph","year":"2019","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.berh.2023.101864_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/annrheumdis-2020-218636","article-title":"Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing","volume":"80","author":"Sandling","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101864_bib16","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ajhg.2020.09.007","article-title":"Analysis of trans-ancestral SLE risk loci identifies unique biologic networks and drug targets in african and European ancestries","volume":"107","author":"Owen","year":"2020","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.berh.2023.101864_bib17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41584-023-00948-y","article-title":"Precision medicine in systemic lupus erythematosus","volume":"19","author":"Fasano","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib18","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.4049\/jimmunol.165.10.5970","article-title":"Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus","volume":"165","author":"Odendahl","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib19","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.10949","article-title":"Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus","volume":"48","author":"Jacobi","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2023.101864_bib20","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/art.23498","article-title":"Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95","volume":"58","author":"Jacobi","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2023.101864_bib21","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/art.39559","article-title":"Enhanced tyrosine phosphatase activity underlies dysregulated B cell receptor signaling and promotes survival of human lupus B cells","volume":"68","author":"Fleischer","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib22","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/art.42157","article-title":"Plasmablast-like phenotype among antigen-experienced CXCR5-CD19low B cells in systemic lupus erythematosus","volume":"74","author":"Szelinski","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib23","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.4049\/jimmunol.2000343","article-title":"Naive- and memory-like CD21(low) B cell subsets share core phenotypic and signaling characteristics in systemic autoimmune disorders","volume":"205","author":"Freudenhammer","year":"2020","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib24","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41591-020-0769-8","article-title":"Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in patients with lupus","volume":"26","author":"Kotliarov","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.berh.2023.101864_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213941","article-title":"B\u00a0cell kinetics upon therapy commencement for active extrarenal systemic lupus erythematosus in relation to development of renal flares: results from three phase III clinical trials of belimumab","volume":"23","author":"Parodis","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.berh.2023.101864_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/BOR.0000000000000576","article-title":"Postactivated B cells in systemic lupus erythematosus: update on translational aspects and therapeutic considerations","volume":"31","author":"Schrezenmeier","year":"2019","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2023.101864_bib27","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/art.40897","article-title":"Enhanced programmed death 1 and diminished programmed death ligand 1 up-regulation capacity of post-activated lupus B cells","volume":"71","author":"Stefanski","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.635615","article-title":"Deep phenotyping of CD11c(\u00fe) B cells in systemic autoimmunity and controls","volume":"12","author":"Rincon-Arevalo","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/BOR.0000000000000865","article-title":"B\u00a0cells in systemic lupus erythematosus","volume":"34","author":"Szelinski","year":"2022","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib30","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.cell.2021.02.015","article-title":"B\u00a0cell-specific XIST complex enforces X-inactivation and restrains atypical B cells","volume":"184","author":"Yu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.berh.2023.101864_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001258","article-title":"Therapeutic implications of the anergic\/postactivated status of B cells in systemic lupus erythematosus","volume":"6","author":"D\u00f6rner","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2023.101864_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.635615","article-title":"Deep phenotyping of CD11c+ B cells in systemic autoimmunity and controls","volume":"12","author":"Rincon-Arevalo","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13075-021-02557-0","article-title":"The expansion of activated naive DNA autoreactive B cells and its association with disease activity in systemic lupus erythematosus patients","volume":"23","author":"Wangriatisak","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2023.101864_bib34","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-Inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.berh.2023.101864_bib35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/08916930310001625952","article-title":"Microarray analysis of interferon-regulated genes in SLE","volume":"36","author":"Crow","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.berh.2023.101864_bib36","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s42003-019-0382-x","article-title":"Gene expression analysis delineates the potential roles of multiple interferons in systemic lupus erythematosus","volume":"2","author":"Catalina","year":"2019","journal-title":"Commun Biol"},{"key":"10.1016\/j.berh.2023.101864_bib37","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/biomedicines11030864","article-title":"Optimal selection of IFN-\u03b1-Inducible genes to determine type I interferon signature improves the diagnosis of systemic lupus erythematosus","volume":"11","author":"Demers-Mathieu","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.berh.2023.101864_bib38","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/annrheumdis-2021-221425","article-title":"Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials","volume":"81","author":"Vital","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101864_bib39","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1093\/rheumatology\/keaa187","article-title":"Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility","volume":"59","author":"Aue","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2023.101864_bib40","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3389\/fimmu.2018.01957","article-title":"Up-regulation of TLR7-mediated IFN-\u03b1 production by plasmacytoid dendritic cells in patients with systemic lupus erythematosus","volume":"9","author":"Sakata","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib41","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI89931","article-title":"A\u00a0TLR9-dependent checkpoint governs B cell responses to DNA-containing antigens","volume":"127","author":"Sindhava","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.berh.2023.101864_bib42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41584-020-00544-4","article-title":"Toll-like receptor signalling in B cells during systemic lupus erythematosus","volume":"17","author":"Fillatreau","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib43","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1182\/blood-2005-07-2650","article-title":"U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7","volume":"107","author":"Savarese","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.berh.2023.101864_bib44","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2023.101864_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/art.42482","article-title":"Elevated levels of interferon-\u03b1 act directly on B cells to breach multiple tolerance mechanisms promoting autoantibody production","author":"Ferri","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31179-x","article-title":"The protein tyrosine phosphatase PTPN22 negatively regulates presentation of immune complex derived antigens","volume":"8","author":"Clarke","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2023.101864_bib47","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(13)60954-X","article-title":"Immunopathogenic mechanisms of systemic autoimmune disease","volume":"382","author":"Wahren-Herlenius","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2023.101864_bib48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.smim.2006.03.008","article-title":"Role of PTPN22 in type 1 diabetes and other autoimmune diseases","volume":"18","author":"Bottini","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000270","article-title":"Interferon pathway in SLE: one key to unlocking the mystery of the disease","volume":"6","author":"R\u00f6nnblom","year":"2019","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.berh.2023.101864_bib50","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1038\/s41467-020-19918-z","article-title":"Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity","volume":"11","author":"Psarras","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.berh.2023.101864_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn2263","article-title":"Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation","volume":"14","author":"Billi","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.berh.2023.101864_bib52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa2118024","article-title":"Trial of anti-BDCA2 antibody litifilimab for cutaneous lupus erythematosus","volume":"387","author":"Werth","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2023.101864_bib53","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138345","article-title":"Accelerating Medicines Partnership in SLE network; Raychaudhuri S, Petri M. Integrated urine proteomics and renal single-cell genomics identify an IFN-\u03b3 response gradient in lupus nephritis","volume":"5","author":"Fava","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.berh.2023.101864_bib54","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/art.40653","article-title":"Stratification of systemic lupus erythematosus patients into three groups of disease activity progression according to longitudinal gene expression","volume":"70","author":"Toro-Dom\u00ednguez","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196117","article-title":"Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: clinical\/pathologic associations and etiologic mechanisms","volume":"13","author":"Wither","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.berh.2023.101864_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103025","article-title":"Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus","volume":"136","author":"Lindblom","year":"2023","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.berh.2023.101864_bib57","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/art.41610","article-title":"Integrative analysis reveals a molecular stratification of systemic autoimmune diseases","volume":"73","author":"Barturen","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib58","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140380","article-title":"Patient ancestry significantly contributes to molecular heterogeneity of systemic lupus erythematosus","volume":"5","author":"Catalina","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.berh.2023.101864_bib59","doi-asserted-by":"crossref","first-page":"906","DOI":"10.4049\/jimmunol.1302112","article-title":"Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus","volume":"192","author":"Palanichamy","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib60","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/art.40142","article-title":"Bone marrow-derived mesenchymal stem cells from patients with systemic lupus erythematosus have a senescence-associated secretory phenotype mediated by a mitochondrial antiviral signaling protein-interferon-\u03b2 feedback loop","volume":"69","author":"Gao","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib61","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/ard.2006.065003","article-title":"In\u00a0vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus","volume":"66","author":"Hepburn","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101864_bib62","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaut.2019.05.002","article-title":"Transitional B cells in quiescent SLE: an early checkpoint imprinted by IFN","volume":"102","author":"Dieudonn\u00e9","year":"2019","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.berh.2023.101864_bib63","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.bor.0000135453.70424.1b","article-title":"Interferon-alpha in systemic lupus erythematosus","volume":"16","author":"Crow","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib64","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.celrep.2018.06.046","article-title":"B-Cell-Intrinsic type 1 interferon signaling is crucial for loss of tolerance and the development of autoreactive B cells","volume":"24","author":"Domeier","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.berh.2023.101864_bib65","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1093\/rheumatology\/keu249","article-title":"Interferon-\u03b1-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes","volume":"53","author":"L\u00f3pez","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2023.101864_bib66","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13075-020-02177-0","article-title":"The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis","volume":"22","author":"Wilkinson","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2023.101864_bib67","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.41187","article-title":"B\u00a0cell tetherin: a flow cytometric cell-specific assay for response to type I interferon predicts clinical features and flares in systemic lupus erythematosus","volume":"72","author":"El-Sherbiny","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib68","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrrheum.2014.33","article-title":"The BAFF\/APRIL system in SLE pathogenesis","volume":"10","author":"Vincent","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib69","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3389\/fimmu.2018.02285","article-title":"BAFF and BAFF-receptor in B cell selection and survival","volume":"9","author":"Smulski","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107982","article-title":"Stromal cell-contact dependent PI3K and APRIL induced NF-\u03baB signaling prevent mitochondrial- and ER stress induced death of memory plasma cells","volume":"32","author":"Cornelis","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.berh.2023.101864_bib71","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.4049\/jimmunol.179.11.7276","article-title":"Regulated expression of BAFF-binding receptors during human B cell differentiation","volume":"179","author":"Darce","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib72","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4049\/jimmunol.1001120","article-title":"The structure of the TNFRSF13C promoter enables differential expression of BAFF-R during B cell ontogeny and terminal differentiation","volume":"185","author":"Mihalcik","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib73","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"BLISS-52 Study Group. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2023.101864_bib74","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/14712598.2021.1895744","article-title":"Belimumab: a step forward in the treatment of systemic lupus erythematosus","volume":"21","author":"Depascale","year":"2021","journal-title":"Expet Opin Biol Ther"},{"key":"10.1016\/j.berh.2023.101864_bib75","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/art.23678","article-title":"Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus","volume":"58","author":"Petri","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2023.101864_bib76","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"Mackay","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib77","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cytogfr.2014.01.001","article-title":"New roles for the BLyS\/BAFF family in antigen-experienced B cell niches","volume":"25","author":"Goenka","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.berh.2023.101864_bib78","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.coi.2014.03.001","article-title":"The imperfect control of self-reactive germinal center B cells","volume":"28","author":"Brink","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1084\/jem.20130505","article-title":"Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation","volume":"211","author":"Goenka","year":"2014","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.berh.2023.101864_bib80","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fimmu.2015.00425","article-title":"Defects in germinal center selection in SLE","volume":"6","author":"Woods","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib81","article-title":"B\u00a0lymphocytes: development, tolerance, and their role in autoimmunity-focus on systemic lupus erythematosus","volume":"2013","author":"Tob\u00f3n","year":"2013","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.berh.2023.101864_bib82","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/BOR.0000000000000825","article-title":"Immune checkpoints and the multiple faces of B cells in systemic lupus erythematosus","volume":"33","author":"Stefanski","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib83","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3389\/fimmu.2019.00965","article-title":"Survival of long-lived plasma cells (LLPC): piecing together the puzzle","volume":"10","author":"Lightman","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib84","article-title":"Generation of human long-lived plasma cells by developmentally regulated epigenetic imprinting","volume":"5","author":"Joyner","year":"2021","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.berh.2023.101864_bib85","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri1886","article-title":"Competence and competition: the challenge of becoming a long-lived plasma cell","volume":"6","author":"Radbruch","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib86","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3389\/fimmu.2019.00721","article-title":"The maintenance of memory plasma cells","volume":"10","author":"Khodadadi","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib87","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1681\/ASN.2010050515","article-title":"Local renal autoantibody production in lupus nephritis","volume":"22","author":"Espeli","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.berh.2023.101864_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2016.02.003","article-title":"Clinical and pathologic considerations of the qualitative and quantitative aspects of lupus nephritogenic autoantibodies: a comprehensive review","volume":"69","author":"Gatto","year":"2016","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.berh.2023.101864_bib89","first-page":"1e182","article-title":"Autoimmunity to nucleosomes related to viral infection: a focus on hapten-carrier complex formation","volume":"17","author":"Van Ghelue","year":"2003","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.berh.2023.101864_bib90","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrrheum.2010.46","article-title":"The role of defective clearance of apoptotic cells in systemic autoimmunity","volume":"6","author":"Mu\u00f1oz","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib91","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3389\/fimmu.2019.01104","article-title":"The dsDNA, anti-dsDNA antibody, and lupus nephritis: what we agree on, what must Be done, and what the best strategy forward could Be","volume":"10","author":"Rekvig","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.808008","article-title":"The anti-DNA antibodies: their specificities for unique DNA structures and their unresolved clinical impact-A system criticism and a hypothesis","volume":"12","author":"Rekvig","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101864_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1422.001","article-title":"Glomerular targets for autoantibodies in lupus nephritis--an apoptotic origin","volume":"1108","author":"Zykova","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.berh.2023.101864_bib94","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2353\/ajpath.2006.051329","article-title":"Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells","volume":"168","author":"Kalaaji","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.berh.2023.101864_bib95","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.ki.5002133","article-title":"Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis","volume":"71","author":"Kalaaji","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.berh.2023.101864_bib96","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1136\/ard.2007.070482","article-title":"Nucleosomes possess a high affinity for glomerular laminin and collagen IV and bind nephritogenic antibodies in murine lupus-like nephritis","volume":"66","author":"Mjelle","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101864_bib97","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/ki.1996.471","article-title":"Heparin and heparinoids prevent the binding of immune complexes containing nucleosomal antigens to the GBM and delay nephritis in MRL\/lpr mice","volume":"50","author":"Van Bruggen","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.berh.2023.101864_bib98","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/art.23626","article-title":"Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus","volume":"58","author":"Van Bavel","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2023.101864_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102443","article-title":"Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: insights from renal ultrastructural findings","volume":"111","author":"Gatto","year":"2020","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.berh.2023.101864_bib100","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1177\/0961203312462267","article-title":"Nephritogenic-antinephritogenic antibody network in lupus glomerulonephritis","volume":"21","author":"Doria","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2023.101864_bib101","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1073\/pnas.1815031116","article-title":"Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA","volume":"116","author":"Serpas","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.berh.2023.101864_bib102","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201138","article-title":"Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus","volume":"218","author":"Hartl","year":"2021","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.berh.2023.101864_bib103","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.immuni.2020.04.015","article-title":"Plasmacytoid dendritic cells and type I interferon promote extrafollicular B cell responses to extracellular self-DNA","volume":"52","author":"Soni","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.berh.2023.101864_bib104","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrrheum.2015.159","article-title":"What is damaging the kidney in lupus nephritis?","volume":"12","author":"Davidson","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib105","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000445","article-title":"Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosus","volume":"8","author":"Rivellese","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.berh.2023.101864_bib106","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/annrheumdis-2022-222212","article-title":"Biological impact of iberdomide in patients with active systemic lupus erythematosus","volume":"81","author":"Lipsky","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101864_bib107","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1056\/NEJMoa2106535","article-title":"Phase 2 trial of iberdomide in systemic lupus erythematosus","volume":"386","author":"Merrill","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2023.101864_bib108","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/art.38074","article-title":"Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus","volume":"65","author":"Carter","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2023.101864_bib109","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/art.27189","article-title":"Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study","volume":"62","author":"Jacobi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2023.101864_bib110","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.34400","article-title":"Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus","volume":"64","author":"Stohl","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2023.101864_bib111","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/annrheumdis-2021-eular.248","article-title":"POS0680 belimumab add-on therapy mobilises memory B cells into the circulation of patients with SLE","volume":"80","author":"Arends","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"suppl 9","key":"10.1016\/j.berh.2023.101864_bib112","article-title":"Efficacy and safety of subcutaneous belimumab (BEL) and rituximab (RTX) sequential therapy in patients with systemic lupus erythematosus: the phase 3, randomized, placebo-controlled BLISS-BELIEVE study [abstract]","volume":"73","author":"Aranow","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib113","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaut.2018.03.003","article-title":"The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus","volume":"91","author":"Kraaij","year":"2018","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.berh.2023.101864_bib114","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/art.41466","article-title":"Phase II randomized trial of rituximab plus cyclophosphamide followed by belimumab for the treatment of lupus nephritis","volume":"73","author":"Atisha-Fregoso","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib115","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.7326\/M21-2078","article-title":"Effectiveness of belimumab after rituximab in systemic lupus erythematosus : a randomized controlled trial","volume":"174","author":"Shipa","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.berh.2023.101864_bib116","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1016\/S2665-9913(22)00332-0","article-title":"Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial","volume":"5","author":"Shipa","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib117","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.berh.2023.101864_bib118","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.berh.2017.10.002","article-title":"Diagnostic and prognostic tests in systemic lupus erythematosus","volume":"31","author":"Vasquez-Canizares","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.berh.2023.101864_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.852162","article-title":"Early changes in B and plasma cell subsets and traditional serological markers as predictors of SRI-4 response to therapy in systemic lupus erythematosus","volume":"9","author":"Parodis","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.berh.2023.101864_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.796508","article-title":"Early B cell and plasma cell kinetics upon treatment initiation portend flares in systemic lupus erythematosus: a post-hoc analysis of three phase III clinical trials of belimumab","volume":"13","author":"Parodis","year":"2022","journal-title":"Front Immunol"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694223000505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694223000505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T19:52:50Z","timestamp":1718826770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694223000505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":120,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1521694223000505"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2023.101864","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translational implications of newly characterized pathogenic pathways in systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2023.101864","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101864"}}